|
Match
|
Document |
Document Title |
|
|
US20140213644 |
Formulations and Methods for Prevention and Treatment of Oral Allergy Syndrome
A method and formulation for the prevention and treatment for Oral Allergy Syndrome (OAS), also referred to as Pollen-associated Food Allergy Syndrome (PFAS), is disclosed. The formulation... |
|
|
US20120100229 |
Treatment and Prevention of White Matter Injury with KATP Channel Activators
The present invention includes a method of treating or preventing a CNS white matter injury in a patient in need thereof. The invention also includes a method of stimulating proliferation of a CNS... |
|
|
US20120088824 |
DOSAGE UNIT COMPRISING A PROSTAGLANDIN ANALOG FOR TREATING CONSTIPATION
A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention includes a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The... |
|
|
US20150258159 |
Method of Modulating Oxidative Stress, Inflammation, or Impaired Insulin Sensitivity with Grape Seed Extract
Method for modulating oxidative stress, inflammation, and impaired insulin sensitivity in a subject by using a grape seed extract, the method being useful in modulating post-prandial oxidative... |
|
|
US20120244084 |
HERBAL EXTRACTS AND FLAVOR SYSTEMS FOR ORAL PRODUCTS AND METHODS OF MAKING THE SAME
The invention provides a method for preparing an herbal extract and a flavor system comprising an herbal extract produced by the process. The invention also provides a flavor system comprising an... |
|
|
US20150064261 |
Multiparticulate L-Menthol Formulations and Related Methods
A multiparticulate dosage form includes a plurality of individual spheroidal enteric coated particulates having (a) a diameter of 0.1 to 2.5 mm; (b) a solid core containing an effective amount of... |
|
|
US20110046120 |
TREATMENT OF IMPULSE CONTROL DISORDERS
The present disclosure provides methods and compositions for treating Impulse Control disorders including, for example, pathological gambling using α2-adrenergic agonists, β-adrenergic receptor... |
|
|
US20130225540 |
SUPPRESSION OF GLIAL FIBRILLARY ACIDIC PROTEIN
Provided herein are methods of decreasing glial fibrillary acidic protein (GFAP) levels in a cell. Such methods include administering an effective amount of a GFAP lowering compound to the cell.... |
|
|
US20130011488 |
Systems, Methods, and Formulations for Treating Cancer
A method and compositions for treating cancer is described using at least two epigenetic modifiers. In various embodiments, hyperbaric oxygen therapy and glycolytic inhibition therapy are used as... |
|
|
US20110150775 |
GENOMIC APPROACHES TO FETAL TREATMENT AND DIAGNOSIS
The present invention provides systems for developing and/or testing therapies for prenatal diseases and conditions including Down Syndrome. The present invention also provides diagnostic methods... |
|
|
US20130143958 |
DOSAGE UNIT COMPRISING A PROSTAGLANDIN ANALOG FOR TREATING CONSTIPATION
A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention includes a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The... |
|
|
US20140228428 |
CYNARA SCOLYMUS EXTRACTS FOR THE TREATMENT OF DYSLIPIDAEMIA
The present invention relates to the preparation of Cynara scolymus leaf extracts, which are useful for the prevention and treatment of dyslipidaemia, in particular to increase HDL cholesterol in... |
|
|
US20130303604 |
Method of Using Tea Polyphenols for Prevention and Treatment of Malignant Tumors in a Hematopoietic System
Tea polyphenols are used to prevent or treat tumors such as leukemia and myeloma, malignant tumors in a hematopoietic system. The tea polyphenols are tea extracts comprising EGCG, EGC, and ECG, or... |
|
|
US20120264703 |
Methods And Compositions For The Treatment Of Anxiety Disorders, Including Post Traumatic Stress Disorder (PTSD) And Related Central Nervous System (CNS) Disorders.
The present invention provides novel methods and formulations for treating anxiety disorders, including Post Traumatic Stress Disorder, in human subjects employing coordinate treatment using α and... |
|
|
US20140161844 |
CROSSLINKER ENHANCED REPAIR OF CONNECTIVE TISSUES
A protein crosslinker delivery device includes a body and a protein crosslinker held in a synthetic or natural biodegradable polymer. The body, a coating on the body, or an attachment to the body... |
|
|
US20140287024 |
NANOPARTICLE-BASED DELIVERY SYSTEM WITH OXIDIZED PHOSPHOLIPIDS AS TARGETING LIGANDS FOR THE PREVENTION, DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS
Disclosed are nanoparticle-based medicine/nutrient delivery system that are coated or incorporated with oxidized phospholipids as targeting ligands. Such delivery systems can specifically target... |
|
|
US20110033406 |
PRESERVED PRODUCT; AND PRESERVATIVE COMPOSITION
A preservative composition held under acidic conditions comprises at least one flavonoid and at least one antimicrobial auxiliary. It is useful as a constituent of a product to be preserved, such... |
|
|
US20140073611 |
METHODS FOR DRUG SCREEN USING ZEBRAFISH MODEL AND THE COMPOUNDS SCREENED THEREFROM
The disclosure relates to a platform of using zebrafish in screening candidates for treating and/or preventing myopia and keratoconus disease. The disclosure is mainly based on that Lumican, one... |
|
|
US20120178757 |
Method For The Prevention Of Cancer Metastasis
A method is provided for the prevention of cancer metastasis in a patient comprising administering an adrenergic receptor antagonist to a patient in need thereof. The invention also includes an... |
|
|
US20140378539 |
CANNABINOIDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN
The present invention relates to cannabinoids for use in the treatment of neuropathic pain. Preferably the cannabinoids are one or more phytocannabinoids of: cannabigerol (CBG), cannabichromene... |
|
|
US20140107192 |
CANNABINOIDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN
The present invention relates to cannabinoids for use in the treatment of neuropathic pain. Preferably the cannabinoids are one or more phytocannabinoids of: cannabigerol (CBG), cannabichromene... |
|
|
US20150166472 |
NOVEL SIGMA RECEPTOR LIGANDS AND METHODS OF MODULATING CELLULAR PROTEIN HOMEOSTASIS USING SAME
The present invention includes compounds useful in preventing, treating or ameliorating Sigma-related disorders or diseases. The compounds of the invention can modulate cellular protein... |
|
|
US20130136811 |
Compositions and Methods for Pain Reduction
Compositions containing four-herb extract combination or Wogonin are useful in methods for the reduction of pain. A four-herb combination is used to treat pain as well as reduce or prevent... |
|
|
US20120094956 |
Treatment of Cancer with Specific RXR Agonists
A method of treating cancer is disclosed comprising administering to a patient in need of such treatment a RXR agonist at a level below the RAR activating threshold and at or above the RXR... |
|
|
US20110318338 |
TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
The present application provides methods of prevention and/or treatment of breast cancer in a subject by inhibiting expression of PAX2. In the cancer treatment methods disclosed, the method of... |
|
|
US20110243937 |
TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
The present application provides methods of prevention and/or treatment of breast cancer in a subject by inhibiting expression of PAX2. In the cancer treatment methods disclosed, the method of... |
|
|
US20110229467 |
TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
The present application provides methods of prevention and/or treatment of breast cancer in a subject by inhibiting expression of PAX2. In the cancer treatment methods disclosed, the method of... |
|
|
US20150217025 |
CROSSLINKER ENHANCED REPAIR OF KNEE MENISCUS
A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a... |
|
|
US20130267477 |
METHOD OF USING NUTRITIONAL COMPOUNDS DIHYDROQUERCETIN (TAXIFOLIN) AND ARABINOGALACTAN IN COMBINATION WITH DIHYDROQUERCETIN (TAXIFOLIN) TO REDUCE AND CONTROL CARDIOMETABOLIC RISK FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND HYPERCHOLESTEROLEMIA
The method of using nutritional compounds including Dihydroquercetin (taxifolin), Arabinogalactan and Arabinogalactan combined with Dihydroquercetin (taxifolin) to reduce and control... |
|
|
US20110300227 |
MALIGNANT NEOPLASM TREATMENT PROTOCOL
Methods, compositions, and strategies for the treatment of malignant neoplasms are presented herein. The treatment modalities are directed towards exploiting characteristics of cancer cells as... |
|
|
US20150065438 |
PREPACKAGED STERILE SYRINGE OR CONTAINERS WITH VARIOUS SUBSTANCE CONCENTRATIONS WITH OR WITHOUT BIOACTIVE REAGENT
A prepackaged sterile syringe or bottle with various concentrations of tissue and organ biologically stimulating reagents i.e., dextrose, various anthocyanins, anthocyanidins and/or their various... |
|
|
US20100298425 |
Use of Tocotrienols for Elevating IKBKAP Gene Expression and Treating Familial Dysautonomia
The present invention provides methods for elevating IKBKAP gene expression and the level of functional IKAP protein in cells, which are beneficial to human individual, such as an individual... |
|
|
US20150182493 |
Methods for Treating Burn and Scar Injury using Tocotrienol Compositions
The present invention provides methods to improve scar and burn outcome utilizing tocotrienols. In particular, various skin pathologies may be treated using the present methods. The present... |
|
|
US20120128797 |
METHOD FOR TREATMENT OF CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME
The present invention provides methods for treating constipation-predominant irritable bowel syndrome comprising administering to a patient in need thereof, a polymeric proanthocyanidin... |
|
|
US20120076770 |
Modulation of autophagy and and serotonin for treatment of multiple myeloma related diseases
THE INVENTION RELATES TO compounds, proteins and methods of treatment therewith. Aspects of embodiments of the invention further relates to compounds and methods of treatment for bone, bone... |
|
|
US20100203166 |
METHODS OF PREVENTING RESPIRATORY INFECTIONS
Methods for inhibiting the development of respiratory infections in humans are disclosed. One embodiment of the methods comprises pouring a predetermined amount of an oral rinse, capable of... |
|
|
US20140005135 |
STABLE FORMULATIONS FOR PARENTERAL INJECTION OF SMALL MOLECULE DRUGS
Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous... |
|
|
US20130245113 |
USE OF A POLYPHENOL FOR THE TREATMENT OF A CANCEROUS OR PRE-CANCEROUS LESION OF THE SKIN
The present invention refers to a method for treating cancerous or precancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to... |
|
|
US20110166219 |
USE OF A POLYPHENOL FOR THE TREATMENT OF A CANCEROUS OR PRECANCEROUS LESION OF THE SKIN
The present invention refers to a method for treating cancerous or precancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to... |
|
|
US20140315994 |
METHOD FOR TREATING GASTROINTESTINAL DISORDER
The present invention relates to a method for the long term treatment of gastrointestinal disorders in a human subject, which comprises administering an effective amount of a halogenated... |
|
|
US20120329736 |
Treatment for gastrointestinal disorders using a selective, site-activated binding system
The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems... |
|
|
US20150087698 |
SOLVENT ADDITION AND REMOVAL IN THE HYDROGENATION OF CATMINT OIL
Disclosed are methods for treating catmint oil. The treated catmint oil can be used for the production of hydrogenated catmint oil, which is enriched in the insect repellent, dihydronepetalactone,... |
|
|
US20140194504 |
DIAGNOSIS AND TREATMENT METHODS FOR ENTRY OF GASTROINTESTINAL CONTENTS INTO RESPIRATORY TRACT
A method of diagnosing in a subject for the purpose of determining if the subject's gastrointestinal contents has entered the subject's respiratory tract. The qualitative analysis can be also... |
|
|
US20140194503 |
DIAGNOSIS AND TREATMENT METHODS FOR ENTRY OF GASTROINTESTINAL CONTENTS INTO RESPIRATORY TRACT
A method of diagnosing in a subject for the purpose of determining if the subject's gastrointestinal contents has entered the subject's respiratory tract. The qualitative analysis can be also... |
|
|
US20140194502 |
DIAGNOSIS AND TREATMENT METHODS FOR ENTRY OF GASTROINTESTINAL CONTENTS INTO RESPIRATORY TRACT
A method of diagnosing in a subject for the purpose of determining if the subject's gastrointestinal contents has entered the subject's respiratory tract. The qualitative analysis can be also... |
|
|
US20120022129 |
Targeting of Histone Deacetylase 2, Protein Kinase CK2, and Nuclear Factor NRF2 For Treatment of Inflammatory Diseases
Methods for the treatment or prevention of diseases which are caused by the degradation of histone deacetylase 2 (HDAC2) in cells are described. The diseases which may be treated by the methods of... |
|
|
US20110009351 |
SCREENING ASSAY TO IDENTIFY CORRECTORS OF PROTEIN TRAFFICKING DEFECTS
The present invention relates to a novel assay or screen for identifying compounds with potential therapeutic value for the treatment of protein trafficking diseases such as Cystic Fibrosis (CF)... |
|
|
US20130251732 |
TARGETING OF CYP1B1 IN THE TREATMENT OF HEAD AND NECK CANCER AND LUNG CANCER
Methods for inhibiting the motility or proliferation of premalignant and malignant cells are provided. Methods for treating a malignancy of the head and neck and for treating a malignancy of the... |
|
|
US20100310508 |
METHODS OF TREATMENT INVOLVING p21/CIP1
The onset ratios and pathological conditions of collagen-induced arthritis and adjuvant arthritis in model mice and rats, respectively, were successfully ameliorated by topically expressing the... |
|
|
US20140234295 |
ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in... |